Swedish biomedical company Xintela has launched an American study to assess its stem cell therapy regime in treating cartilage damage in horse joints.
Xintela, which is active in regenerative medicine and cancer research, says the study, involving eight horses, is being conducted in collaboration with a group at New York’s Cornell University.
Xintela’s stem cells are derived from equine fat tissue.
Read more:Â http://www.horsetalk.co.nz/2016/04/26/study-stem-cells-horse-fat-fetlock/#ixzz473quYJ3l
